Skip to main content

Table 3 Review of the clinical description of SMARCB1 mutation patients affected with non-rhabdoid tumors

From: SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis

Reference Clinical context Observation
[2] 1 familial schwannomatosis case report, initial description
[3] 28 sporadic + 15 familial non-vestibular schwannomatosis patients 2/28 + 5/15 mutations
[4] 1 familial schwannomatosis with multiple meningiomas case report
[5] 47 NF2-negative patients with multiple meningiomas 0/47
[9] 21 sporadic schwannomatosis patients 1/21 mutation
[10] 1 familial meningiomatosis case report